1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, 2023–2031
5. Key Insights
    5.1. Applications of real-time PCR in the continuum of care and patient management.
    5.2. Strengths of dPCR and qPCR
    5.3. Key product/brand Analysis
    5.4. Technological Advancements
    5.5. Top 3 players operating in the market space
    5.6. COVID Impact Analysis
6. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2023–2031
        6.3.1. Quantitative PCR
            6.3.1.1. Reagents & Consumables
            6.3.1.2. Instruments
            6.3.1.3. Software
        6.3.2. Digital PCR
            6.3.2.1. Reagents & Consumables
            6.3.2.2. Instruments
            6.3.2.3. Software
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2023–2031
        7.3.1. Clinical Applications
        7.3.2. Research Applications
        7.3.3. Pathogen Testing
        7.3.4. Oncology Testing
        7.3.5. Blood Screening
        7.3.6. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2023–2031
        8.3.1. Hospitals & Diagnostic Centers
        8.3.2. Research Laboratories & Academic Institutes
        8.3.3. Pharmaceutical & Biotechnology Companies
        8.3.4. Clinical Research Organizations
        8.3.5. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2023–2031
        10.2.1. Quantitative PCR
            10.2.1.1. Reagents & Consumables
            10.2.1.2. Instruments
            10.2.1.3. Software
        10.2.2. Digital PCR
            10.2.2.1. Reagents & Consumables
            10.2.2.2. Instruments
            10.2.2.3. Software
    10.3. Market Value Forecast, by Application, 2023–2031
        10.3.1. Clinical Applications
        10.3.2. Research Applications
        10.3.3. Pathogen Testing
        10.3.4. Oncology Testing
        10.3.5. Blood Screening
        10.3.6. Others
    10.4. Market Value Forecast, by End-user, 2023–2031
        10.4.1. Hospitals & Diagnostic Centers
        10.4.2. Research Laboratories & Academic Institutes
        10.4.3. Pharmaceutical & Biotechnology Companies
        10.4.4. Clinical Research Organizations
        10.4.5. Others
    10.5. Market Value Forecast, by Country, 2023–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2023–2031
        11.2.1. Quantitative PCR
            11.2.1.1. Reagents & Consumables
            11.2.1.2. Instruments
            11.2.1.3. Software
        11.2.2. Digital PCR
            11.2.2.1. Reagents & Consumables
            11.2.2.2. Instruments
            11.2.2.3. Software
    11.3. Market Value Forecast, by Application, 2023–2031
        11.3.1. Clinical Applications
        11.3.2. Research Applications
        11.3.3. Pathogen Testing
        11.3.4. Oncology Testing
        11.3.5. Blood Screening
        11.3.6. Others
    11.4. Market Value Forecast, by End-user, 2023–2031
        11.4.1. Hospitals & Diagnostic Centers
        11.4.2. Research Laboratories & Academic Institutes
        11.4.3. Pharmaceutical & Biotechnology Companies
        11.4.4. Clinical Research Organizations
        11.4.5. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2023–2031
        12.2.1. Quantitative PCR
            12.2.1.1. Reagents & Consumables
            12.2.1.2. Instruments
            12.2.1.3. Software
        12.2.2. Digital PCR
            12.2.2.1. Reagents & Consumables
            12.2.2.2. Instruments
            12.2.2.3. Software
    12.3. Market Value Forecast, by Application, 2023–2031
        12.3.1. Clinical Applications
        12.3.2. Research Applications
        12.3.3. Pathogen Testing
        12.3.4. Oncology Testing
        12.3.5. Blood Screening
        12.3.6. Others
    12.4. Market Value Forecast, by End-user, 2023–2031
        12.4.1. Hospitals & Diagnostic Centers
        12.4.2. Research Laboratories & Academic Institutes
        12.4.3. Pharmaceutical & Biotechnology Companies
        12.4.4. Clinical Research Organizations
        12.4.5. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        12.5.1. China
        12.5.2. India
        12.5.3. Japan
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2023–2031
        13.2.1. Quantitative PCR
            13.2.1.1. Reagents & Consumables
            13.2.1.2. Instruments
            13.2.1.3. Software
        13.2.2. Digital PCR
            13.2.2.1. Reagents & Consumables
            13.2.2.2. Instruments
            13.2.2.3. Software
    13.3. Market Value Forecast, by Application, 2023–2031
        13.3.1. Clinical Applications
        13.3.2. Research Applications
        13.3.3. Pathogen Testing
        13.3.4. Oncology Testing
        13.3.5. Blood Screening
        13.3.6. Others
    13.4. Market Value Forecast, by End-user, 2023–2031
        13.4.1. Hospitals & Diagnostic Centers
        13.4.2. Research Laboratories & Academic Institutes
        13.4.3. Pharmaceutical & Biotechnology Companies
        13.4.4. Clinical Research Organizations
        13.4.5. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2023–2031
        14.2.1. Quantitative PCR
            14.2.1.1. Reagents & Consumables
            14.2.1.2. Instruments
            14.2.1.3. Software
        14.2.2. Digital PCR
            14.2.2.1. Reagents & Consumables
            14.2.2.2. Instruments
            14.2.2.3. Software
    14.3. Market Value Forecast, by Application, 2023–2031
        14.3.1. Clinical Applications
        14.3.2. Research Applications
        14.3.3. Pathogen Testing
        14.3.4. Oncology Testing
        14.3.5. Blood Screening
        14.3.6. Others
    14.4. Market Value Forecast, by End-user, 2023–2031
        14.4.1. Hospitals & Diagnostic Centers
        14.4.2. Research Laboratories & Academic Institutes
        14.4.3. Pharmaceutical & Biotechnology Companies
        14.4.4. Clinical Research Organizations
        14.4.5. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company (2021)
    15.3. Company Profiles
        15.3.1. Bio Rad Laboratories
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Thermo Fisher Scientific, Inc.
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Qiagen
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. F. Hoffmann La Roche Ltd.
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Abbott Laboratories
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Agilent Technologies
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. BD
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Danaher Corporation
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Merck KGaA
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. Takara Bio, Inc.
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			